Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ginecol Obstet Mex ; 82(2): 111-22, 2014 Feb.
Artigo em Espanhol | MEDLINE | ID: mdl-24779267

RESUMO

UNLABELLED: Due high rates of unplanned pregnancy and unsafe abortion in young women in Latin America intrauterine contraception, by its great contraceptive efficacy, should be offered by the public services of health in a more generalized way. However, some negative prejudices prevail over the perception of its benefits. The aim of this article was to explore the most relevant myths around this contraceptive method in Latin America and make a review of the literature to allay the fears of their use by young and nulliparous women. METHODS: Descriptive and retrospective study. Search for information in Embase and PubMed with emphasis on clinical randomized studies, studies of cases and controls, meta-analyses and systematic reviews which show risks and benefits of intrauterine contraception. RESULTS: Evidence shows that intrauterine contraception has few contraindications for young women and nulliparous; for this reason it must be as an effective public health strategy to reduce unplanned pregnancies and unsafe abortions. CONCLUSIONS: We identified the major barriers to the use of intrauterine contraception in Latin America and evidence for each one of them in the bibliography. Doctors of first contact in health systems should now recognize that intrauterine contraception is safe and effective.


Assuntos
Anticoncepção/métodos , Dispositivos Intrauterinos , Gravidez não Planejada , Aborto Induzido/estatística & dados numéricos , Anticoncepção/efeitos adversos , Feminino , Humanos , Dispositivos Intrauterinos/efeitos adversos , América Latina , Gravidez , Saúde Pública , Estudos Retrospectivos
2.
Arch Androl ; 44(3): 207-12, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10864368

RESUMO

Human sperm viability is essential for successful fertilization. Eosin Y is the usually accepted method for sperm viability assessment, though the hypoosmotic swelling test has been proposed for the selection of viable spermatozoa in procedures such as intracytoplasmic sperm injection. The present study was designed to determine the value of hypoosmotic swelling test in the prediction of sperm viability. For this purpose, hypoosmotic swelling and eosin Y were performed in parallel and in combination, on both fresh and freeze-thawed semen. Rates for eosin Y were significantly higher than for the hypoosmotic swelling test in fresh semen, with a weak, though significant correlation between the two tests (r = 0.47, p < 0.05). When both tests were performed in succession (hypoosmotic swelling test followed by eosin Y), 14.6% of swollen sperm incorporated the dye. Following exposure to hypoosmotic conditions, sperm viability decreased by 35%. When sperm were killed by freezing, hypoosmotic swelling test rates were higher than eosin Y. Results indicate that these two tests cannot be used interchangeably, since 15% of the swollen sperm apparently died, suggesting that plasma membrane integrity is lost before the capacity to maintain osmotic equilibrium.


Assuntos
Espermatozoides/fisiologia , Congelamento , Humanos , Masculino , Pressão Osmótica
3.
Riv Neurol ; 59(4): 146-9, 1989.
Artigo em Italiano | MEDLINE | ID: mdl-2617026

RESUMO

Seventy-one EEGs (0.49%) of 53 patients, out of 14,458 recordings, contained triphasic waves: twenty-nine were patients with metabolic encephalopathies and 24 were demented patients (16 of these had a presumptive diagnosis of Alzheimer's disease and the other eight of mult-infarct dementia). Demented subjects with metabolic disorders are included in the metabolic encephalopathies group. In all of the cases of Alzheimer's disease, triphasic waves were atypical: in 14 they occurred singly or in short bursts, in 10 they had occipital predominance and in 2 they were bilateral but asymmetrical. In 5 cases, triphasic waves were associated with myoclonus and in 2 of them they occurred in long runs with a pseudo-periodic pattern. In these cases the distinction from Creutzfeldt-Jakob disease was based on neuropathologic findings.


Assuntos
Doença de Alzheimer/fisiopatologia , Encefalopatias Metabólicas/fisiopatologia , Demência por Múltiplos Infartos/fisiopatologia , Eletroencefalografia , Idoso , Humanos , Pessoa de Meia-Idade
4.
Epilepsy Res ; 3(2): 160-6, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2707251

RESUMO

The efficacy and safety of oral vigabatrin (VGB) as add-on therapy in the long-term treatment of poorly controlled epilepsy were evaluated in 19 patients with complex partial seizures, either with or without secondary generalization. The study was run with a single-blind, placebo-controlled, crossover design, and included 2 months of placebo and 13-15 months of treatment with VGB, at doses ranging from 1 to 4 g/day. Of the 14 patients who completed the trial, 2 were seizure free, in 5 seizure frequency dropped by more than 75% and in another 5 by more than 50% with respect to baseline. The decrease in seizure frequency in the group as a whole was significant at all observation points of the trial. Three patients were not entered into the long-term phase due to lack of improvement (an increase in seizure frequency was observed in one of them), and 2 were excluded later because improvement disappeared leading to unauthorized changes in comedication. Side effects were mild and never caused discontinuation of treatment. In conclusion, VGB showed a remarkable efficacy and safety in the long-term treatment of complex partial seizures.


Assuntos
Aminocaproatos/uso terapêutico , Epilepsia do Lobo Temporal/tratamento farmacológico , Administração Oral , Adolescente , Adulto , Aminocaproatos/efeitos adversos , Aminocaproatos/farmacocinética , Relação Dose-Resposta a Droga , Feminino , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Vigabatrina
5.
Riv Neurol ; 57(6): 333-5, 1987.
Artigo em Italiano | MEDLINE | ID: mdl-3452233

RESUMO

A 20-year-old epileptic patient developed hypertension during CBZ treatment, without any demonstrable etiological factor. After CBZ discontinuation, a gradual normalization of blood pressure values was observed. The authors discuss the possible role of ADH in the production of this unfrequent side effect.


Assuntos
Carbamazepina/efeitos adversos , Epilepsia/tratamento farmacológico , Hipertensão/induzido quimicamente , Adulto , Feminino , Humanos , Hipertensão/sangue , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...